Sleep apnea syndrome in the elderly

Area of Science:

• Gerontology
• Sleep Medicine
• Cardiovascular Health

Background:

• Sleep apnea syndrome (SAS) is a prevalent sleep disorder with significant morbidity and mortality, typically affecting middle-aged men.
• Prevalence estimates of SAS in the elderly vary widely (18-73%), with previous studies limited by inconsistent diagnostic criteria and methodologies.
• The association between SAS in the elderly and cardiovascular disease or cognitive impairment remains controversial and requires further investigation.

Purpose of the Study:

• To critically evaluate the prevalence and clinical significance of sleep apnea syndrome in the elderly population.
• To address the limitations of previous studies and establish more reliable estimates for SAS in older adults.
• To clarify the relationship between SAS, cardiovascular health, and cognitive function in the elderly.

Main Methods:

• Review and analysis of existing studies on SAS prevalence in elderly cohorts.
• Application of standardized diagnostic criteria for sleep-disordered breathing (SDB), including apnea-hypopnea index (AHI) thresholds.
• Comparison of clinical characteristics and health outcomes between elderly SAS patients and age-matched controls.

Main Results:

• The most robust study estimates SAS prevalence at 18% in the general elderly population, though many remain asymptomatic.
• Using a higher diagnostic threshold (10+ events/hour), elderly SAS patients exhibit more sleep disturbances, depression, and cognitive deficits compared to controls.
• A high AHI is a significant predictor of mortality in the elderly, particularly during sleep.

Conclusions:

• SAS in the elderly, when appropriately diagnosed, shares similarities with SAS in middle-aged populations.
• Elevated SDB levels represent a substantial risk factor for mortality in older individuals.
• Further research is needed to fully elucidate the long-term impact of SAS on cardiovascular health and cognitive decline in the aging population.